Michael A. Samuel, MD

Transcription

1 California Center for CLINICAL RESEARCH 207 S. Santa Anita Street, Suite P30 San Gabriel, CA Tel: Fax: www. researchcalifornia. corn Michael A. Samuel, MD LICENSE State of California Medical License No. A83237 State of Ohio Medical License State of Pennsylvania Medical License State of New Jersey Medical License DEA: FSO CERTIFICATION Board Certified - American Board of Ophthalmology & MEMBERSHIP American Academy of Ophthalmology American Society of Retinal Specialists The Association for Research in Vision and Ophthalmology PROFESSIONAL California Center for Clinical Research AFFILIATIONS 207 S. Santa Anita, Suite P30 San Gabriel, CA Tel: (626) Fax: (626) W. Huntington Drive, Suite 107 Arcadia, CA Tel: (626) Fax: (626) S. Fairmount Ave., Ste 312 Pasadena, CA Tel: (626) Fax: (626) B Colima Road Hacienda Heights, CA Tel: (626) Fax: (626) Country Club Dr., Ste 109 Rancho Mirage, CA Tel: (760) Fax: (760) Leaders in Clinical Trials

2 CV PAGE E. Artesia Street, Ste 120 Pomona, CA Tel: (909) Tel: (909) EDUCATION & Fellowships: TRAINING Vitreo-Retinal Surgery Doheny Retina Institute / University of Southern California Pediatric Vitreo-Retinal Surgery & Ocular Oncology Children's Hospital Los Angeles University of Southern California Residency: Ophthalmology Henry Ford Health System Detroit, MI Internship: Transitional Year Mount Carmel Medical Center Columbus, OH Graduate: Meharry Medical College M.D. Nashville, TN Undergraduate: Capital University, B.A. Columbus, OH PROFESSIONAL 2010 Present POSITIONS California Center for Clinical Research San Gabriel, CA Medical Director 2009-Present Pasadena, CA

3 CV PAGE Columbus Eye Center The Retina Group Columbus, OH Nationwide Children's Hospital Columbus, OH Wills Eye Hospital Attending Retina Service Philadelphia, PA Thomas Jefferson University Assistant Professor of Ophthalmology Philadelphia, PA Children's Hospital of Philadelphia Clinical Affiliate Philadelphia, PA Central Montgomery Medical Center Lansdale, PA Montgomery Hospital Norristown, PA RESEARCH, "A PHASE III, DOUBLE-MASKED, MULTICENTER, CLINICAL TRIALS RANDOMIZED, ACTIVE TREATMENT-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 0.5mg AND 2.0mg DRUG ADMINISTERED MONTHLY OR ON AN AS NEEDED BASIS (PRN) IN PATIENTS WITH SUBFOVEAL NEOVASCULAR AGE- RELATED MACULAR DEGENERATION" "A 24-MONTH RANDOMIZED, DOUBLE-MASKED, CONTROLLED, MULTICENTER, PHASE IIIB STUDY ASSESSING SAFETY AND EFFICACY OF DRUG PHOTODYNAMIC THERAPY ADMINISTERED IN CONJUNCTION WITH DRUG VERSUS DRUG MONOTHERAPY IN PATIENTS WITH SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION" "DRUG FOR EDEMA OF THE MACULA IN DIABETES: A PHASE 2 STUDY" "A RANDOMIZED, SINGLE-MASKED, LONG-TERM, SAFETY, AND TOLERABILITY STUDY OF INTRAVITREAL DRUG IN

4 CV PAGE 4 SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION" "A DOUBLE-MASKED, RANDOMIZED, CONTROLLED STUDY OF THE SAFETY, TOLERABILITY AND BIOLOGICAL EFFECT OF REPEATED INTRAVITREAL ADMINISTRATION OF DRUG IN PATIENTS WITH DIABETIC MACULAR EDEMA (DME)" "A RANDOMIZED, DOUBLE-MASKED, ACTIVE CONTROLLED PHASE III STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF REPEATED DOSES OF INTRAVITREAL DRUG IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION" "A PHASE III, MULTICENTER, RANDOMIZED, SHAM INJECTION-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF DRUG INJECTION COMPARED WITH SHAM IN SUBJECTS WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION" "A PHASE III, MULTICENTER, RANDOMIZED, SHAM INJECTION-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF DRUG INJECTION COMPARED WITH SHAM IN SUBJECTS WITH MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION" "AN OPEN-LABEL, MULTICENTER EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF DRUG IN SUBJECTS WITH CHOROIDAL NEOVASCULARIZATION (CNV) SECONDARY TO AGE-RELATED MACULAR DEGENERATION (AMD) OR MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION (RVO) WHO HAVE COMPLETED A XXXXXX- SPONSORED DRUG STUDY" "A PHASE III, DOUBLE-MASKED, MULTICENTER, RANDOMIZED, SHAM-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF DRUG INJECTION IN SUBJECTS WITH CLINICALLY SIGNIFICANT MACULAR EDEMA WITH CENTER INVOLVEMENT SECONDARY TO DIABETES MELLITUS" "A PHASE 2, RANDOMIZED, DOUBLE-MASKED, PLACEBO- CONTROLLED, DOSE-RANGING CLINICAL STUDY TO ASSESS THE SAFETY AND EFFICACY OF SUBCONJUNCTIVAL INJECTIONS OF DRUG IN PATIENTS WITH DIABETIC MACULAR EDEMA SECONDARY TO DIABETIC

5 CV PAGE 5 RETINOPATHY" "A RANDOMIZED, DOUBLE MASKED, CONTROLLED PHASE 3 STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF REPEATED INTRAVITREAL ADMINISTRATION OF DRUG IN SUBJECTS WITH MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION (CRVO)" Principal Investigator, CABERNET trial, 2007 Cnv Secondary Amd Treated with BEta RadiatioN Epiretinal Therapy. NeoVista Inc, Fremont, CA Principal Investigator, RADICAL trial, 2007 Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination jar AMD Lesions. QLT Inc. Vancouver, BC Diabetes Research Training Program -Vanderbilt University Vanderbilt University Research Grant Wound healing using the Free Electron Laser (FEL). HONORS & AOS-Knapp Fellowship Award 2004 AWARDS Outstanding Resident Award of 600+ residents in Henry Ford Health System Barsky Award - Study design and implementation HFHS Meharry Public Service Award co-founding the Vanderbilt - Meharry Program for Prenatal Health. PEER REVIEWED Samuel MA, Kaufman SC, Ahee JA, Wee C, Bogorad D. Diffuse PUBLICATIONS lamellar keratitis associated with carboxymethylcellulose sodium 1% (Celluvisc) after laser in situ keratomileusis. J of Cataract & Refract Surg Sep;28(9): Ahee JA, Kaufman SC, Samuel MA. Decreased incidence of epithelial defects during lasik with intraoperative carboxymethylcellulose 0.5% solution. J Cataract Refract Surg. 2002Aug;28(8): Samuel MA, Gandolfo C, Desai DR. Peripapillary retinal detachment after radial optic neurotomy for central retinal vein occlusion. Retina Aug;23(4): Samuel MA, Desai DR, Strassman I, Abusamak M. Intraocular irrigating solutions: a clinical study of BSS Plus and dextrose

6 CV PAGE 6 bicarbonate fortified BSS as an infusate during pars plana vitrectomy. Indian J Ophthalmol Sep;51(3): Trick G, Samuel MA. Clinical applications of short wave length automated perimetry. Comprehensive Ophthalmol Update Nov;4(6): Raman SV, Desai DR, Anderson S, Samuel MA. Visual prognosis in patients with traumatic choroidal rupture. Can J Ophthalmol Apr;39(3): Tawansy KA, Samuel MA. Retinopathy of prematurity: practical surgical management in the new millennium. Techniques in Ophthalmology 2004 Jun;2(2): Kiahmi M, Samuel MA, Desai DR, Imami NR. Familial HLA-A2B7 associated anterior uveitis. Can J Ophthalmol Oct;39(6):664-6 Samuel MA, Desai UR. Ocular trauma associated with Pickwickian Syndrome. Journal of Injury - Online journal 2004, July Kuarana RN, Charonis A, Samuel MA, Gupta A, Tawansy KA. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children. Med Sci Monit Nov 24;11(12):CS75-78 Khurana RN, Samuel MA, Murphree AL, Loo RH, Tawansy KA. Subfoveal nodule in Coats' disease. Clin Experiment Ophthalmol Jun;33(3): Tawansy KA, Samuel MA, Shammas M, Murphree AL. Vitreoretinal complications of retinoblastoma treatment. Retina Sep;26(7 Suppl):S Samuel MA, Equi RA, Chang TS, Mieler W, Jampol LM, Hay D, Yannuzzi LA. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology Aug;114(8): el. Lam HD, Samuel MA, Rao NA, Murphree AL. Retinoblastoma presenting as Coats' disease. Eye Nov 30. Hsu J, Kaiser RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, et al. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina Oct;27(8):

7 CV PAGE 7 ABSTRACTS Samuel MA. Treating CNV Caused By AMD with Verteporfin PDT and Bevacizumab: The Registry ofvisudyne0 AMD Therapy Database. Retina Society Meeting Boston. Samuel MA, Tawansy KA, Oppenheimer N. Rhegmatogenous retinal detachment in neonatal retinopathy of prematurity. ARVO Poster Hill JR, Crawford BD, Samuel MA, Tawansy KA. Evaluation of open-globe injuries of children in the last 15 years. ARVO Poster Samuel MA, Tawansy KA. (2004) Current indications for scleral buckling in neonatal rop retinal detachment. 22"d Annual Meeting American Society of Retina Specialists, San Diego, CA. Paper Shammas MC, Samuel MA, Murphree AL. (2004) Late recurrence of intraocular retinoblastoma. 22"d Annual Meeting American Society of Retina Specialists, San Diego, CA. Paper Lam D, Tawansy KA, Samuel MA. (2004) Smoldering retinopathy of prematurity: late onset neonatal retinal detachment. 22nd Annual Meeting American Society of Retina Specialists, San Diego, CA. Paper Samuel MA, Stewart JM, Tawansy KA. (2004) Open-sky vitrectomy for pediatric retinal detachments. Doheny Eye Institute Alumni Meeting. Los Angeles, CA. Paper. Samuel MA, Tawansy KA. (2003) Top ten reasons for a pediatric vitreo-retinal consult. Doheny Retina Forum, Los Angeles, CA. Paper. Samuel MA, Tawansy KA, Murphree AL. (2003) Vitreo-retinal complications of retinoblastoma. 21st Annual Meeting American Society of Retina Specialists, New York, NY. Paper. Samuel MA, Jackson J, Adusumalli M. (1996). Characterization of the free electron laser (FEL) in a diabetic model of impaired wound healing. Vanderbilt University Diabetes Research Symposium, Nashville, Tennessee. Paper Samuel MA, Kaufman SC, Ahee JA, Wee C, Bogorad D. (2001). Diffuse lanlellar keratitis associated with carboxymethylcellulose sodium 1% (Celluvisc) after laser in situ keratomileusis. Henry Ford Hospital Alumni Meeting -Eye Care Services, Detroit, Michigan.

8 CV PAGE 8 Samuel MA, Desai DR, Strassman I, Abusamak M, Schiffman RM. (2002). Intraocular irrigating solutions: a clinical study of BSS Plus and dextrose bicarbonate fortified BSS as an infusate during pars plana vitrectomy. Henry Ford Hospital Alumni Meeting -Eye Care Services, Detroit, Michigan. Bhatti RA, Samuel MA, Fantin A, Dennehy P, Desai DR, Bachyinski B. (2005). The role of fetal hemoglobin in the development and progression of retinopathy of prematurity. ARVO Poster Pons M, Samuel MA, Murphree AL. (2004) Regression patterns of retinoblastoma after primary chemotherapy and local consolidation. Annual Meeting American Society of Retina Specialists, San Diego, CA. Poster. Khurana R, Charonis A, Samuel MA, Tawansy KA. (2004) Pediatric acute retinal necrosis resistant to acyclovir and responsive to foscarnet. Annual Meeting American Society ofretina Specialists, San Diego, CA. Poster. Samuel MA, Tawansy KA, Murphree AL, Roa NA. (2004) Clinical and fluorescein angiographic characteristics of late-onset retinoblastoma with coats' response in children. ARVO -Poster Lam DH, Tawansy KA, Samuel MA. (2004) Delayed retinal vascular maturation and late onset macular dragging and retinal detachment in neonates with retinopathy of prematurity. ARVO - Poster Khaimi M, Samuel MA, Desai UR, Imami NR, Schiffinan RM. (2002) Familial HLAA2B7 associated anterior uveitis. Retina Congress --The Combined Meeting, San Francisco, California. Poster. Abdulhak MM, Samuel MA, Desai UR, Edwards PA. (2002) Retinal manifestations of patients with sickle cell trait. Retina Congress -The Combined Meeting, San Francisco, California. Poster. Desai UR, Gandolfo CB, Samuel MA. (2002). Timing of macula-on retinal detachment surgery. Retina Congress -The Combined Meeting, San Francisco, California. Poster Deasi UR, Raman SV, Edwards PA, Gandolfo CB, Samuel MA. (2002). Visual outcomes of choroidal ruptures. Retina Congress -The Combined Meeting, San Francisco, California. Poster.

9